Please utilize analysis of Digirad fundamentals to determine if markets are correctly pricing the company. We found thirty-eight available fundamental indicators for Digirad Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Digirad fundamentals including its Shares Outstanding, Price to Sales, Cash per Share, as well as the relationship between Number of Shares Shorted and EBITDA . Given that Digirad has Price to Earning of 16.42 , we urge you verify Digirad Corporation prevailing market performance to make sure the company can sustain itself down the road. Use Digirad to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Digirad to be traded at $5.53 in 30 days.
Digirad Company Summary
Digirad competes with ENCISION INC, Electromed, EDAP TMS, Edwards Lifesciences, and Establishment Labs. Digirad Corporation provides healthcare solutions in the United States and internationally. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Digirad operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 452 people.
Digirad Z Score vs Market Capitalization
Digirad Corporation is rated below average in z score category among related companies. It is rated below average in market capitalization category among related companies .
Digirad Systematic Risk
Digirad Thematic Clasifications
Digirad October 17, 2019 Opportunity Range